StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.71+0.04 (+1.50%)

Close on Nov 18, 2026Market cap $94.21MP/E –Yield –

Anixa Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Anixa Biosciences's market cap was $96.15M on Nov 11, 2026, against $150.65M a year earlier. Over the last 5 years it ranged from $70.73M to $171.66M, with a median of $101.43M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$96.15M-6.7%
2025Dec 31, 2025$103.00M+37.9%
2024Dec 31, 2024$74.70M-38.2%
2023Dec 29, 2023$120.84M-8.0%
2022Dec 30, 2022$131.38M+47.2%
2021Dec 31, 2021$89.25M+19.9%
2020Dec 31, 2020$74.44M+11.6%
2019Dec 31, 2019$66.69M-10.5%
2018Dec 31, 2018$74.50M+90.1%
2017Dec 29, 2017$39.18M-17.1%
2016Dec 30, 2016$47.26M+80.0%
2015Dec 31, 2015$26.26M+8.7%
2014Dec 31, 2014$24.17M-39.2%
2013Dec 31, 2013$39.76M+19.4%
2012Dec 31, 2012$33.30M+71.9%
2011Dec 30, 2011$19.37M-40.0%
2010Dec 31, 2010$32.29M–

More Anixa Biosciences figures

See a number that looks wrong?